20951-14-8 Usage
Uses
Used in Pharmaceutical Industry:
2-Fluoro-1-Methoxy-4-(Methylsulfonyl)benzene is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to facilitate the creation of complex molecular structures that can target specific biological pathways.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Fluoro-1-Methoxy-4-(Methylsulfonyl)benzene is utilized as an intermediate in the development of compounds that can protect crops from pests and diseases, leveraging its reactivity to form new agrochemical entities.
Used in Organic Synthesis:
2-Fluoro-1-Methoxy-4-(Methylsulfonyl)benzene is used as a reagent in organic synthesis, particularly for the preparation of heterocyclic compounds, due to its unique ability to participate in various types of chemical reactions, including nucleophilic and electrophilic processes.
Safety Considerations:
It is important to handle 2-Fluoro-1-Methoxy-4-(Methylsulfonyl)benzene with care, as it can be harmful if inhaled, swallowed, or absorbed through the skin. Additionally, it may cause irritation to the eyes and respiratory system, necessitating proper safety measures during its use in laboratories and industrial settings.
Check Digit Verification of cas no
The CAS Registry Mumber 20951-14-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,9,5 and 1 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 20951-14:
(7*2)+(6*0)+(5*9)+(4*5)+(3*1)+(2*1)+(1*4)=88
88 % 10 = 8
So 20951-14-8 is a valid CAS Registry Number.
20951-14-8Relevant academic research and scientific papers
GPR119 Receptor Agonists
-
Page/Page column 18, (2009/12/05)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
SYNTHESIS OF METHYLSULPHONYL BENZENE COMPOUNDS
-
Page/Page column 11, (2010/11/27)
The present invention relates to a process for the synthesis of l-substituted-2-fluoro-4- methylsulfonylphenyl compounds.
1,2,4-OXADIAZOLE DERIVATIVES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Page/Page column 42, (2010/02/14)
The present invention is directed to novel 1,2,4-oxadiazole derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
